RECTOSIGMOID CANCER

This adverse event was reported 220 times

These drugs are most commonly taken by patients reporting RECTOSIGMOID CANCER:

# Drug Count
0 FLUOROURACIL 19
1 FLUOROURACIL CREAM, 0.5% 19
2 FUROSEMIDE 19
3 FRUQUINTINIB 17
4 OXALIPLATIN 17
5 CLOPIDOGREL 16
6 ESOMEPRAZOLE MAGNESIUM 16
7 CLOPIDOGREL BISULFATE 13
8 APIXABAN 12
9 ATENOLOL 12
See all common drugs associated with RECTOSIGMOID CANCER

RECTOSIGMOID CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FRUQUINTINIB 17 0.0043
1 TOREMIFENE CITRATE 1 0.0023
2 DINOPROSTONE 1 0.0012
3 NALOXONE HCL 1 0.0012
4 MIGLITOL 1 0.0010
5 REGORAFENIB 9 0.0008
6 DASATINIB 6 0.0006
7 DAPRODUSTAT 1 0.0005
8 ATROPINE SULFATE INJECTION 1 0.0004
9 ATROPINE SULFATE MONOHYDRATE 1 0.0004
See all drugs enriched for association with RECTOSIGMOID CANCER